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ABSTRACT
Shiga toxin-producing Escherichia coli (STEC) has been recognized as an
important foodborne pathogen. Of this group, O91 is one of the common
serogroups frequently isolated from patients and food in some countries, with
O91:H21 being previously implicated in hemolytic uremic syndrome (HUS).
Cattle are principle reservoirs for STEC, and studies examining STEC shedding
in cattle often include experimental inoculation of strains of interest using
antibiotic resistance markers for identifiable recovery. However, indigenous fecal
microbes exhibiting similar resistance patterns can confound such studies. Such
was the case in a study by our group when attempting to characterize shedding
patterns of O91:H21 in calves, leading us to seek other, more effective, markers.
Among our strategies was the development of a chromosomally integrated
bioluminescence marker via transposon mutagenesis using a luxCDABE
cassette from Photorhabdus luminescens and a plasmid borne GFP marker via
transformation of the pGFP vector. The luxCDABE marker was inserted on host
chromosome at a site that was 27 nucleotides before the stop codon of gene yihL
and confirmed to have little impact on important virulence genes and growth rate
with a very high stability. In contrast, plasmid borne GFP marker showed poor
stability without the application of appropriate antibiotic selection pressure. For
calves receiving luxCDABE-marked O91:H21, the fecal counts of the organism
ranged from 1.2 x 103 to 1.3 x 104 CFU/g at two days post inoculation and
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decreased to 5.8 to 8.7 x 102 CFU/g or undetectable level after two weeks.
Intestinal contents sampled from various positions at day 14 post inoculation
indicated that cecum and descending colon may be the primary localization sites
of this O91:H21 strain. Compared to antibiotic resistance markers, the use of
bioluminescence markers does not require the restricted pre-inoculation
screening of animals. The enumeration of luxCDABE-marked O91:H21 from
feces and intestinal contents was easily accomplished and confirmed reliable by
M-PCR analysis under the presence of indigenous bacteria which cannot be
eliminated

by

antibiotic-supplemented

selective

plates.

Therefore,

the

chromosomal integrated luxCDABE marker may be a better model for the study
of STEC colonization and shedding in cattle.

Key Words: shiga toxin-producing Escherichia coli (STEC), shedding,
luxCDABE, GFP, marker, O91:H21
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LITERATURE REVIEW
Introduction
During the past two decades, shiga toxin-producing Escherichia coli
(STEC) has emerged as one of the top foodborne pathogens of concern.
According to the last estimate in 1999, STEC causes approximately 100,000
illnesses every year in the US, resulting in 3,000 hospitalizations and 90 deaths
(Mead, Slutsker et al. 1999). Diarrhea is the most common clinical manifestation
among patients (Coia 1998) and is frequently accompanied by blood in the feces.
Some patients, particularly those at the extremes of age, may further develop
life-threatening complications such as hemolytic uremic syndrome (HUS) and
thrombotic thrombocytopenic purpura (TTP) (Griffin and Tauxe 1991; Paton and
Paton 1998; Blanco, Blanco et al. 2004).
Ruminants, especially cattle, are considered the principal reservoir for
STEC. Under natural exposure, infection in cattle only leads to asymptomatic
carriage, with the organism confined within the intestine and shed via feces.
Cattle can persistently shed the organisms in their feces from a few days to
several months (Shere, Bartlett et al. 1998; Menrath, Wieler et al. 2010). Under
typical environmental temperatures, some STEC can survive in feces for more
than 49 days (Wang, Zhao et al. 1996). Contaminated feces can lead to crossinfection or reinfection on the farm, contamination of equipment and meat
products during processing, and direct or indirect contamination of fruits and
vegetables when manure is used for fertilization or contaminates irrigation water.

1

A clear understanding of various STEC shedding patterns in cattle and
factors that could affect the duration and magnitude of the shedding might help
limit STEC carriage in animals and contamination in food. In common practice,
studies examining STEC shedding in cattle usually include experimental
inoculation of strains of interest using antibiotic resistance markers for identifiable
recovery. However, such studies can be confounded by similar antimicrobial
resistance patterns exhibited by indigenous microflora. To date, approximately 40%
of manufactured antibiotics have been used in livestock production systems,
especially as feed supplements for growth promotion purposes (Levy 1998).
Frequent exposure of farm animals to antibiotics creates selection pressure that
may result in an increased proportion of antimicrobial resistant bacteria in an
animal’s fecal flora.
To overcome such problems and to satisfy long-term research strategies
of STEC colonization and shedding in cattle, other more effective markers are
urgently needed. Among various options, bioluminescent and fluorescent
markers appear to be good candidates and their non-destructive physiological
characteristics facilitate real-time monitoring, which could be valuable for in vivo
studies in the future. Bioluminescent markers were of particular interest in the
current study because they are easily detected and have less or no background
interference from host enzymes or culture media.
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STEC classification
The term STEC refers to the ability of the organism to produce a toxin
(Stx1, Stx2, and Stx2 variants) that is homologous to the shiga toxin type I of
Shigella dysenteriae (O'Brien, LaVeck et al. 1982). STEC is also commonly
referred to as verocytotoxin-producing Escherichia coli (VTEC) based on the
observation that shiga toxin had direct cytotoxic effects on cultured Vero cells
(African green monkey kidney cells) (Konowalchuk, Speirs et al. 1977).
Currently, more than four hundred STEC serotypes (Blanco, Padola et al.
2004) have been identified based on the recognition of their O (somatic
lipopolysaccharide) and H (flagella) antigens (Nataro and Kaper 1998).
Among STEC, O157:H7 is the most notable serotype. It was first isolated
from a California patient with bloody diarrhea in 1975. However the public health
significance of this organism was not of high concern until it caused a multistate
outbreak of hemorrhagic colitis (HC) associated with a fast-food chain in 1982
(Riley, Remis et al. 1983). It is estimated that O157:H7 causes approximately
73,000 infections and 60 deaths every year in the US, representing two thirds of
total STEC infections (Tserenpuntsag, Chang et al. 2005). HUS cases caused by
the organism account for more than 80% of typical HUS cases in North America,
where HUS is the leading cause of acute renal failure in children (Banatvala,
Griffin et al. 2001). The delayed or defective sorbitol fermentation feature in
O157:H7 distinguishes it from other E. coli strains and has provided a convenient
detection method for routine screening. Since 1996, O157:H7 infections have
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been monitored under the Foodborne Diseases Active Surveillance Network
(FoodNet), a component of the CDC’s Emerging Infections Program (EIP), in
collaboration with the USDA and FDA. According to their most recent report, a
significant decrease was observed in the incidence of reported O157:H7
infections in 2009, compared to that in the previous 3 years (CDC 2010).
Food, especially beef products, is considered the major source of O157
infections.

Historically,

several

large

outbreaks

were

associated

with

consumption of contaminated ground beef, including incidences in 1982 and
1993 (Rangel, Sparling et al. 2005). Therefore, in 1994, the USDA Food Safety
and Inspection Service (FSIS) declared O157:H7 as an adulterant in food, which
allows agents to seek a recall if food is confirmed to be contaminated with
O157:H7.
Compared to infections caused by other STEC serotypes, O157:H7
infections appear to be more likely to result in severe illnesses. In the US,
approximately 80% of diarrhea patients infected with O157:H7 develop HC,
compared to only about 40% in non-O157 STEC infections; meanwhile, 8% of
HC caused by O157:H7 may progress to HUS, whereas HUS is rare in non-O157
STEC infections (CDC, 2007). In some other countries, where O157:H7 is overall
less prevalent, such as Argentina which holds the world’s highest incidence of
HUS in children, O157:H7 was involved in 50-60% of HUS cases (Bustamante,
Lucchesi et al. 2009). In Europe, several extensively-conducted surveys
concluded that although 80% of STEC isolates from patients with diarrhea
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belonged to non-O157 serogroups, approximately 81% of isolates from HUS
patients were O157:H7 (Parma, Sanz et al. 2000).
Infections caused by non-O157 STEC were documented almost the same
time as those of O157:H7 (Karmali, Petric et al. 1985). However, the infection
incidence is typically underestimated partly due to the challenges of developing
rapid identification techniques. Meanwhile, since most clinical laboratories don’t
routinely screen for these organisms in diarrhea stool samples, only isolates
associated with outbreaks or severe illnesses have been reported. In the US,
surveillance data associated with non-O157 infections in FoodNet has only
become available since 2000. The number of reported infections has increased
every year since then. In 2000, non-O157 infections only represented 5.5% of the
STEC infections, whereas in 2009, the percentage increased to 36.5% (CDC
2010). In other countries, the frequency of non-O157 infections among total
STEC infections varies, ranging from 19 to 100% (Johnson, Thorpe et al. 2006).
Over one hundred non-O157 STEC serotypes have been associated with
human diseases. However, these serotypes are not equally pathogenic. Some
serotypes are capable of causing illnesses indistinguishable from those caused
by O157:H7, while some others are only capable of causing diarrhea.
Pathogenesis of each serotype largely depends on its virulence profile. However,
genomic analyses of O157, O26, O111 and O103 found a surprisingly great
inclusion of mobile genetic elements including prophages, integrative elements
and plasmids, with many virulence-conferring genes located in these regions
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(Ogura, Ooka et al. 2009), which may contribute to an increased virulence in
previously low-virulent strains, via horizontal gene transfer.
Predominant non-O157 STEC in outbreaks is limited to only several
serogroups and may vary geographically. In the US, infections caused by six
serogroups, including O26, O103, O111, O121, O45 and O145, represent more
than 70% of total non-O157 infections (CDC 2010). Due to several recent
outbreaks related to O145 and O26, there has been pressure from the public to
broaden the adulterant criteria to at least these six most frequently isolated nonO157 STEC serogroups. However, opposing voices from The American Meat
Institute stated that non-O157:H7 STEC has not yet become a public health
emergency in beef products. In Europe, O26, O111, O145, O103 and O91 are
the five most common serogroups among isolates from patients. Serogroup O91,
although rarely reported in the US, is the most frequent serogroup among adult
STEC infected patients in Germany (Werber, Beutin et al. 2008).

Putative virulence factors
Shiga toxins (Stxs) are directly associated with the development of HC,
HUS and TTP complications. They can be divided into two major groups, Stx1
and Stx2, based on the similarity level of amino acid sequence to Stx of Shigella
dysenteriae. Compared to Stx1, Stx2 has only approximately 50-60% aahomology to the Stx of S. dysenteriae (Weinstein, Jackson et al. 1988) and
cannot be neutralized by anti Stx of S. dysenteriae and anti Stx1
immunoglobulins. Moreover, Stx2 possesses more heterogeneity, with variants
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Stx2, Stx2c, Stx2c2, Stx2d, Stx2e and Stx2f being recognized in different STEC
serotypes (Muthing, Schweppe et al. 2009). Generally, bacteria able to produce
Stx2 are considered more virulent than those that only produce Stx1.
Stxs are comprised of a catalytic A subunit of 32-kDa and a pentameric B
subunit (7.7-kDa for each monomer) that binds the toxin to specific cell surface
receptors (Paton and Paton 1998). Most Stx variants bind specifically to Gb3
(globotriaosylceramide) receptors (Lingwood, Law et al. 1987) with the exception
of Stx2e which preferentially binds to Gb4 (globotetraosylceramide) (DeGrandis,
Law et al. 1989) receptors. The human kidney expresses high levels of Gb 3 in
both the cortex and medulla (Boyd and Lingwood 1989), which may explain the
fact that the kidney is one of the most affected organs in severe STEC illnesses.
On the other hand, human large intestinal epithelium, which is considered the
major site for STEC colonization (Paton and Paton 1998), lacks the presence of
Gb3 receptors (Holgersson, Jovall et al. 1991), and therefore is not affected by
the cytotoxicity of Stxs. Various studies have showed the translocation of both
Stx1 and Stx2 from apical to the baselateral side of the Gb 3-negative epithelial
cell monolayer, without observing apparent cell damage (Acheson, Moore et al.
1996; Schuller, Frankel et al. 2004). It is currently proposed that transcellular
transcytosis, in particular through the macropinocytosis pathway (Maluykova,
Gutsal et al. 2008), may facilitate translocation of Stxs across the intestinal
epithelium to underlying tissues and into the blood circulation causing damage to
the endothelium, which may also induce mucosal damage via ischemia or
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apoptosis signals (Schuller, Frankel et al. 2004) and create the translocation
pathway through epithelial lesions.
Upon binding to the receptor, Stxs are internalized and undergo
retrograde transport via the Golgi to either the endoplasmic reticulum
(ER)/nucleus that can lead to high cytotoxicity (Arab and Lingwood 1998) or to
endosomal/lysosomal compartments that leads to toxin inactivation, as has been
observed in bovine tissues (Hoey, Sharp et al. 2003). During internalization, the
C-terminal of the A subunit is cleaved to generate the form with ribosomal RNA
N-glycosidase activity with the potential to inhibit protein synthesis through
cleavage of an adenine residue from the 28s rRNA subunit at the position where
elongation factor 1-dependent binding of aminoacyl tRNA to the 60s rRNA takes
place (Saxena, O'Brien et al. 1989), and further leads to cell apoptosis.
Pathogenicity is also facilitated by the ability of the organism to adhere to
the intestinal mucosa and colonize in the gut. The eae gene has been widely
used as an indicatior of potential efficient colonization. Its product, an outer
mambrane protein, called intimin, mediates an intimate attachment of STEC to
the surface of enterocytes. This process, together with the effacement of brush
border microvilli and cytoskeletal rearrangement, is defined as attaching and
effacing (A/E) adherence (Shaw, Cleary et al. 2005), which is mediated by a
chromosomally-located pathogenicity island named the locus of enterocyte
effacement (LEE). Besides intimin, LEE also includes genes coding a
translocated intimin receptor (Tir), a type III secretion system (TTSS) and some
secreted effector proteins such as EspA, EspB and EspD, which are considered
8

to be involved in the initial host-bacterium interaction and Tir translocation (Ebel,
Podzadel et al. 1998). LEE-positive STEC includes several serogroups that are
commonly implicated in HUS cases and outbreaks, such as O157, O26, O103
and O145 (Padola, Sanz et al. 2004).
In certain LEE-negative STEC, such as O113:H21 and O91:H21, an
alternative adhesin, STEC autoagglutinating adhesin (Saa) has been identified
(Paton, Srimanote et al. 2001). Saa is encoded by single open reading frame
located on a virulent megaplasmid. STEC naturally carrying the saa gene, as well
as saa-transformed E. coli K12 strain, showed high adherence to epithelial cells
with phenotype different from that of typical LEE-induced A/E adherence. Only
microvillus effacement, but neither cytoskeletal rearrangements nor intimate
adherence, was observed (Dytoc, Ismaili et al. 1994; Paton, Srimanote et al.
2001). It is proposed that the number of a 37-aa repeated element in the Cterminal of Saa may affect adherence properties (Paton, Srimanote et al. 2001).
Beyond the above, other mechanisms or factors affecting Saa-mediated
adherence are not clear.
In addition to intimin and Saa, other adhesins have been recognized from
both LEE-positive and negative STEC. The chromosomally encoded adhesin, Iha,
is one example (Tarr, Bilge et al. 2000; Newton, Sloan et al. 2009).
The harboring of other accessory virulence factors could enhance STEC
virulence. Enterohemolysin (EhxA) is found in most of the STEC isolates
associated with human diseases. This plasmid-encoded hemolysin showed
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cytotoxicity to many cell lines and may function synergistically with Stxs (Schmidt,
Beutin et al. 1995). By lysing erythrocytes, hemoglobin is released as a potential
source of iron (Law and Kelly 1995), influencing the survival of STEC in the ironlimiting intestinal environment. The rpoS gene was reported to mediate an acid
tolerance response upon the exposure of STEC to stomach acid (Gorden and
Small 1993). The SubAB toxin could contribute to severe illnesses through
single-site cleavage of an ER chaperon (Paton, Beddoe et al. 2006) and is more
prevalent in LEE-negative serotypes (Newton, Sloan et al. 2009).

STEC infections in human
STEC infections in humans can lead to a spectrum of diseases, ranging
from asymptomatic carriage and watery diarrhea to life-threatening complications,
such as HUS and TTP (Griffin and Tauxe 1991; Paton and Paton 1998; Blanco,
Blanco et al. 2004). Diarrhea typically starts 3-4 days post-ingestion. In
approximately 40-80% of cases, diarrhea progresses to HC, which is
characterized as visible blood in feces and, frequently, severe abdominal cramps
and vomiting (Riley, Remis et al. 1983). Most patients recover from HC within
approximately one week. However, for a small percentage of patients, especially
children less than 4 years old and the elderly and immune-compromised patients,
HC can be life-threatening.
Approximately 7% of HC cases in O157:H7 infection progress to HUS
(Coia 1998). The rate is not well investigated for infections caused by the various
non-O157 serotypes, but is considered to be lower. Patients usually develop
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HUS approximately one week following the onset of diarrhea. The clinical
features include microangiopathic hemolytic anemia, thrombocytopenia and
acute renal failure (Coia 1998). Syndromes may be further complicated by the
involvement of damage to the central nervous system (CNS) and other organs.
HUS has a mortality rate of 3-5%, and as high as 30% of HUS patients suffer
permanent complications including chronic renal failure and hypertension (Tarr
1995).
TTP is another complication more commonly observed among adult
patients. Clinical features are similar to that of HUS, except renal damage is
relatively less pronounced in TTP; instead, patients tend to suffer more
neurological impairments, including severe headache, stroke, seizure, and CNS
deterioration (Morrison, Tyrrell et al. 1986).
Because diarrhea, abdominal cramping and bloody stools are not specific
to STEC infections, the course of diagnosis is frequently prolonged and nonspecific therapies are applied to patients. In the case of HUS, hemodialysis and
blood transfusion are often required. Antibiotic treatment is controversial in STEC
infections. Certain antibiotics functioning as DNA synthesis inhibitors, such as
mitomycin and ciprofloxacin, were showed to induce Stx-encoding bacteriophage
and increase Stx production (al-Jumaili, Burke et al. 1992; Walterspiel,
Ashkenazi et al. 1992; Matsushiro, Sato et al. 1999; Zhang, McDaniel et al. 2000),
which could increase the risk of HUS development. Although such effects have
not been observed with antibiotics that target cell wall synthesis, transcription
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and translation (Kurioka, Yunou et al. 1999; McGannon, Fuller et al. 2010),
antibiotic treatment is currently not recommended for STEC infections.
Food is considered the major transmission vehicle of O157:H7 and,
probably, many non-O157 STEC. Beef products (Bell, Goldoft et al. 1994) in
particular, as well as dairy products (Upton and Coia 1994; Goh, Newman et al.
2002; Allerberger, Friedrich et al. 2003), fruits and vegetables (Fukushima,
Hashizume et al. 1999) have all been implicated in STEC outbreaks or sporadic
cases. Contaminated water has been reported as causing at least 49 O157:H7
outbreaks and 7 non-O157 outbreaks (Kasper et al. 2010). Direct contact to
animals or infected people has recently become an important route for STEC
transmission (Akiba, Kimura et al. 2005; Hanna, Humphreys et al. 2007). Personperson contact was especially mentioned as the most common transmission
route among reported non-O157 STEC infections (Kasper et al. 2010).

STEC infection in cattle
Ruminant animals, especially cattle, are considered the principle
reservoirs of STEC O157:H7, and appear to be reservoirs of most non-O157
STEC as well. The prevalence of O157:H7, in published reports of the past 30
years, ranged from 0.3 to 27.3% in beef cattle and from 0.2 to 48.8% in dairy
cattle; the corresponding prevalence of non-O157 STEC ranged from 4.6 to 55.9%
and from 0.4 to 74.0%, respectively (Hussein and Sakuma 2005; Hussein 2007).
Experimental infections with STEC, even with inoculum doses as high as
1010 CFU, are commonly nonpathogenic to healthy cattle, but occasionally result
12

in transient nonhemorrhagic diarrhea in calves (Cray and Moon 1995). However,
neonatal calves are considered susceptible to, at least, O157:H7 infections
(Dean-Nystrom, Bosworth et al. 1997).
Stx1 produced by STEC has been previously showed to bind the lower
crypt bovine epithelium in the jejunum, ileum and cecum (Hoey, Sharp et al. 2003;
Schuller, Frankel et al. 2004). Stx2, possessing higher cytotoxicity, was not
detected in these tissues, indicating bovine intestinal epithelium may not express
the Stx2-specific Gb3 receptor isoform (Schuller, Frankel et al. 2004). Stx1
bound to bovine epithelium was eventually delivered to endosomal/lysosomal
compartments, resulting in toxin inactivation (Falguieres, Mallard et al. 2001).
Together with the fact that bovine endothelial cells do not express Gb3 receptors
(Pruimboom-Brees, Morgan et al. 2000), the above may explain the resistance of
cattle to STEC-induced diseases.
Organisms shed in bovine feces are considered the ultimate source of
STEC contamination. Under natural infection, the concentration of O157:H7 in
cattle feces was showed to range from 2 x 102 to 8.7 x 104 CFU/g, with individual
animals continuously testing positive for the organism in feces for 1 to 16 weeks
(Shere, Bartlett et al. 1998). In another survey conducted at a breeding farm in
Japan (Widiasih, Ido et al. 2004), fecal shedding of O157:H7 lasted from less
than 1 week to 10 weeks, with the concentrations varying from 4 to higher than
1.1 x 105 CFU/10g feces, and shedding of O26 lasted from less than 1 week to
less than 3 weeks, with the concentration ranging from 3 to 2.4 x 103 CFU/10g. A
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similar magnitude of fecal shedding was also reported in another study
(Robinson, Wright et al. 2004).
A subset of naturally infected cattle excreted larger quantities of O157:H7,
higher than 104 CFU/g feces (Chase-Topping, Gally et al. 2008), compared with
most other individuals in the population. These individuals are defined as supershedders or persistent-shedders, as the O157:H7 shedding magnitude was
positively correlated with the duration of culture-positive status (Davis, Rice et al.
2006). Recent studies have included specific shedding duration in the definition,
such as more than 3 consecutive months (Lim, Li et al. 2007; Carlson,
Nightingale et al. 2009) or more than half of fecal samples consecutively testing
positive for more than 4 months (Menrath, Wieler et al. 2010). Super-shedders
typically comprise approximately 4% of the population according to a statistical
model (Matthews, McKendrick et al. 2006), but may contribute to approximately
80% of O157:H7 transmission to uninfected cattle (Matthews, Low et al. 2006).
Non-O157 STEC super-shedders were recently also reported (Menrath, Wieler et
al. 2010).
To establish experimental infection, oral inoculation with high doses of
approximately 108 to 1010 CFU of STEC is commonly preferred (Cray and Moon
1995; Besser, Richards et al. 2001) and is reported to result in fecal shedding
patterns that are considerably variable among individuals and experiments. The
shedding durations have been reported to range from 20 to 43 days (Sanderson,
Besser et al. 1999), or in another study (Cray and Moon 1995), 7 to 20 weeks for
calves less than 14 weeks old and 2 to 14 weeks for 1-year-old adult cattle. In
14

one study (Cray and Moon 1995), most calves that received 1010 CFU of
O157:H7 had fecal shedding concentrations of 104 to 107 CFU/g during the first
four days post-inoculation (PI), with several calves shedding at an extremely high
level (approximately 108 to 109 CFU/g) in first two days PI. The shedding levels
dropped sharply within the first two weeks PI to an undetectable shedding level
within 30 days, with individual calves discontinuously shedding the organism at
approximately 102-104 CFU/g thereafter throughout the 144-day experiment.
Persistent shedding is closely related to successful colonization of the
intestinal mucosa, whereas organisms in intestinal contents could be quickly
eliminated from animals. The recto-anal junction (RAJ) has been identified as a
primary colonization site of O157:H7 in cattle (Naylor, Low et al. 2003), which is
consistent with the observations that infection of O157:H7 in most bovine in vivo
studies didn’t cause apparent A/E lesions on the intestinal epithelium (Brown,
Harmon et al. 1997) with the exception at the RAJ (Lim, Li et al. 2007); and
colonization at the terminal rectum, especially the RAJ, is highly recognized
among persistent shedding cattle. However, it is not clear whether the RAJ is
also the primary colonization site for non-O157 STEC.
Many STEC adherence factors involved in the pathogenesis of human
infection, such as the LEE, Saa, and some accessory adherence factors (Efa1,
Iha, etc.), also contribute to the colonization in the bovine intestine (DeanNystrom, Bosworth et al. 1998; Stevens, van Diemen et al. 2002; Jenkins, Perry
et al. 2003; Sheng, Lim et al. 2006). Studies identified several predominant
PFGE-types

of

O157:H7

in

persistent-shedders,
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possessing

enhanced

adherence ability to human intestinal cells in vitro (Cobbold, Hancock et al. 2007;
Carlson, Nightingale et al. 2009). Moreover, phage type 21/28 of O157:H7 was
associated with persistent shedding (Halliday, Chase-Topping et al. 2006). This
phage type demonstrated altered regulation of the type III secretion system,
which also resulted in up-regulated colonization of the organism (Chase-Topping,
Gally et al. 2008).
Diet composition and feed regimen could also have an impact on STEC
shedding. Low nutrient (Kudva, Hunt et al. 1997), easily fermented feed
compositions (such as barley) (Bach, Selinger et al. 2005) and the practice of
fasting animals during transportation (Kudva, Hatfield et al. 1995) were frequently
linked to higher or more persistent STEC shedding in cattle. This is probably due
to the effects of reducing the secondary fermentation in the large intestine, which
could result in decreasing colonic volatile fatty acid (VFA) concentrations and
increasing pH, providing a more hospitable intestinal environment for STEC
survival and proliferation.
Efforts have been made to reduce the shedding level of STEC in cattle.
Several STEC vaccines have been developed based on the immunization with
bacterial proteins conferring the ability to colonize, including intimin (van Diemen,
Dziva et al. 2007), Efa1 (Stevens, van Diemen et al. 2002; van Diemen, Dziva et
al. 2007), EspA (Dziva, Vlisidou et al. 2007), H7 flagellin (McNeilly, Naylor et al.
2008) and LEE-coding secreted proteins (Potter, Klashinsky et al. 2004; Van
Donkersgoed, Hancock et al. 2005). Administration of these vaccines
successfully induced the host immune response with up-regulated IgA and/or IgG
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to various contents; however, only the vaccines with secreted protein preparation
or purified H7 flagellin have thus far resulted in delayed shedding peak and/or
reduced colonization rate, and their effect in reducing STEC prevalence in cattle
population was limited (Van Donkersgoed, Hancock et al. 2005).
Providing probiotics also is a promising practice for reducing STEC
shedding in ruminants. The use of various probiotics, including direct-fed
microbials (Ohya, Marubashi et al. 2000; Lema, Williams et al. 2001; Brashears,
Jaroni et al. 2003), competitive exclusion (Zhao, Doyle et al. 1998; Zhao, Tkalcic
et al. 2003) and yeast culture (Liou, Sheng et al. 2009), have been reported to
shorten STEC shedding period or significantly reduce the shedding concentration.
A pre-harvest diet shift from grain to forage was previously proposed to
reduce pathogenic E. coli in cattle based on a research result that generic E. coli
populations in grain-fed cattle were 1000-fold higher than in forage-fed cattle
(Diez-Gonzalez, Callaway et al. 1998). The influence of forage or grain diet in
STEC shedding has been under long-time debate with various studies showing
conflicting results. On one hand, some results showed a sudden diet shift from
grain to hay reduced O157:H7 prevalence in cattle populations (Keen et al.,
1999). On the other hand, other studies indicated that experimentally inoculated
forage-fed cattle shed O157:H7 for a longer duration with higher concentrations
than grain-fed cattle (Kudva, Hatfield et al. 1995; Van Baale, Sargeant et al.
2004). Because forage quality, components, bacteria inoculation dose, or
sampling methods were not standardized in these studies, caution should be
taken before extrapolating or drawing conclusions from these results.
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Prevalence of antibiotic resistant bacteria in farm animals
Antibiotic resistance markers have been widely used for identifiable
recovery of bacterial strains of interest from various environmental and animal
samples, such as feces. Pre-inoculation selection of animals for experiments and
the use of appropriate selective media or specific growth conditions commonly
ensure the efficient use of these markers. However, in a recent study, the use of
antibiotic resistance markers was confounded by similar resistance patterns
exhibited by indigenous bacteria in cattle feces and the selection of calves free of
bacteria that are resistant to specific antibiotics was not well satisfied, which
indicates the prevalence of antibiotic resistant bacteria may be underestimated,
especially under the extensive use of antibiotics in animal agriculture.
As recently as 2009, FDA released the first government report, which
indicated approximately 29 million pounds of antimicrobial drugs had been sold
or distributed for the use in food animals in the US in 2009 (FDA, 2010). The
administration of antibiotics to livestock is defined by two major categories: for
disease prevention and treatment under therapeutic levels; and, more
extensively, for growth enhancement under non-therapeutic levels. Other than
the benefits brought to the livestock production industry, antibiotics that are
commonly added to feed or water at low concentrations could have a direct
impact on intestinal microbial populations. Through long term selection pressure,
a higher prevalence of antibiotic resistance genes in the intestinal microflora may
result. To date, the outcomes associated with the extensive application of
antibiotics have emerged as an important public health issue. In particular, efforts
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have been made to survey the prevalence of antibiotic resistant bacteria in
animal fecal samples, as an indication of their prevalence in the intestinal
microflora. It was reported in one study that 80.3% of 270 non-specific E. coli
isolates and 97% of 101 Salmonella isolates collected from cattle feces, hides
and carcasses were resistant to at least one antibiotic (Fluckey, Loneragan et al.
2007). High proportions of antibiotic resistant strains were also observed in
Campylobacter isolates (60% of 448 isolates) derived from the feces of US
feedlot cattle (Englen, Fedorka-Cray et al. 2005), in Campylobacter isolates (68.1%
of 72 isolates) from poultry, beef and dairy cattle (Oporto, Juste et al. 2009), and
in intestinal E. coli isolates (72.1%) from healthy pigs in a German production unit
(Schierack, Kadlec et al. 2009). Among the resistant isolates in above studies,
multidrug resistance was commonly observed. Isolates from livestock samples
are frequently resistant to tetracycline, quinolones, ampicillin, chloramphenicol,
kanamycin, streptomycin (Oporto, Juste et al. 2009; Schierack, Kadlec et al.
2009).

Bioluminescence
Bioluminescence is an enzymatically catalyzed luminescent phenomenon
possessed by a remarkably diverse group of species in nature. Among this group,
luminescent bacteria are the most abundant species. Light emission in bacteria is
achieved by a luciferase-catalyzed oxidation of reduced flavin mononucleotide
(FMNH2) and long chain fatty aldehyde (RCHO) to flavin mononucleotide (FMN)
and corresponding fatty acid, with the excess energy released in the form of
blue/green light (

MAX

≈ 490nm) (Meighen 1991). Both FMNH2 and molecular
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oxygen are common metabolic products naturally available in living cells (Close,
Patterson et al. 2010), and all of the other genes necessary for the luminescence
reaction, including genes luxAB coding luciferase and genes luxCDE coding the
fatty acid reductase complex for RCHO synthesis, are included within a single
luxCDABE operon.
The

majority

of

luminescent

bacteria

naturally

exist

in

marine

environments except Photorhabdus, which are symbiotic pathogens of terrestrial
insects (Farmer, Jorgensen et al. 1989). Other than being once isolated from
human wounds (Colepicolo, Cho et al. 1989), luminescent bacteria are seldom
reported in animals. To date, bacterial bioluminescence has been widely used as
a reporter in gene expression or as a whole cell biosensor. Unlike some other
non-destructive live-cell image tools, interference from endogenous signals is
much less of a problem with the use of bioluminescence. And compared to green
(GFP) and red (DsRed) fluorescent proteins, bioluminescence has the
advantanges of significant shorter incubation times and lower detection limits
(Hakkila, Maksimow et al. 2002). Lux genes developed from Vibrio fischeri, Vibrio
harveyi and Photorhabdus luminescens are currently the most well adapted
bacterial lux systems. Luciferases from Vibrio fischeri and Vibrio harveyi prefer
working temperatures of less than 30 ºC and 37 ºC, respectively. In contrast,
luciferase from Photorhabdus luminescens can remain stable at temperatures as
high as 45 ºC (t1/2 > 3h) (Szittner and Meighen 1990), which enables more
flexible applications and is more suitable for studies conducted in animal models
or expression of lux genes in eukaryotic cells.
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By fusing a complete lux operon (luxCDABE) or luciferase gene luxAB to
the promoter of interest, the strength and regulation of gene expression at the
transcription level can be measured in terms of luminescence intensity. In a
similar way, the concentration and distribution of biluminescent transformed cells
can be monitored. Utilization of luxCDABE biosensors has been reported in the
monitoring of E. coli O157:H7 distribution and colonization on beef carcass
surface tissues (Siragusa, Nawotka et al. 1999), infection of Staphylococcus
aureus in antibiotic-treated or untreated mice (Francis, Joh et al. 2000),
assessment of the invasion kinetics of Salmonella enterica Typhimurium in
different eukaryotic cell lines (Flentie, Qi et al. 2008), and other studies. In
practice, bioluminescent-marked bacteria have been used to evaluate the
efficiency of newly developed antibiotics (Ulitzur 1986). Because a very low level
of bioluminescence can be detected, bacteriophage with inserted luxCDABE are
used to provide an early detection of foodborn pathogens in food or water
samples (Griffiths 1993; Brigati, Ripp et al. 2007).

Green fluorescent protein
Biological fluorescence is generated from chromophore at an excited state.
In the case of native Green Fluorescence Protein (GFP) from the jellyfish
Aequorea victoria, upon being excited at 395nm wavelength, emits a bright green
fluorescent light with a major peak at 508nm (Tsien 1998). The tri-peptide motif
Ser65-Tyr66-Gly67 close to the center of protein structure spontaneously forms a
chromophore with fluorescence-emission ability in the presence of molecular
oxygen (Tsien 1998). This maturation process is independent of any A. victoria
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specific enzymes or cofactors, therefore fluorescence can be generated where
GFP is expressed.
Similar to bioluminescence, GFP has been widely used in cell biology
research to monitor gene expression, protein-protein interaction, protein
localization in real-time and as a whole cell biosensor to detect, for example,
pathogen distribution and concentrations. Compared to the other fluorescent
dyes, GFP has a much lower cytotoxicity and was showed to have little impact on
cell physiology or protein activity even when expressed at high levels (Chalfie, Tu
et al. 1994). However, unlike bioluminescence, the use of GFP, especially as a
whole cell biosensor, can be confounded by autofluorescence emitted from
certain cellular molecules in the host or from some media when they are excited
at appropriate wavelengths. Meanwhile, fluorescence is not enzymatically
catalyzed; in other words, fluorescent light intensity is positively correlated with
the number of mature chromophore and the level of GFP expression. To
overcome background noise from endogenous fluorescence, GFP, when used as
a biosensor of bacteria, is typically expressed from plasmids rather than from
chromosomes, to accomplish higher expression levels. Considering the rare
occurrence of indigenous fluorescence in human pathogens, GFP cell biosensor
has been used in studies to determine the concentration and duration of survival,
for example, E. coli O157:H7 and Salmonella Typhimurium in animal manure,
soil (Himathongkham, Bahari et al. 1999; Franz, van Diepeningen et al. 2005),
and plant tissues under different treatments. Stability of plasmid-borne GFP
marker in bacteria might be questioned when there’s no additional selection
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pressure being application, however, in the above studies, green fluorescence
was persistently detected from plasmid-expressed GFP strains after inoculation
in soil and manure for at least 80 days (Franz, van Diepeningen et al. 2005;
Lagendijk, Validov et al. 2010). To our knowledge, however, most studies
inoculated plasmid-expressed GFP pathogens directly to animal feces or other
environmental samples. Few studies have tested the feasibility of using such
GFP markers for the recovery of pathogens from feces after oral inoculation of
animals and passed through the GIT, where they are subjected to stressful
conditions from very diverse intestinal microflora and complicated physical
conditions. This question will be tested in the current study.

Goals of this research
STEC has recently emerged as an important group of foodborne
pathogens in many countries. As principle reservoirs of the organism, cattle are
considered to be the ultimate sources of contamination. A previous study
(Hussein 2007) estimated the prevalence of STEC among feedlot cattle ranged
from 0.3 to 19.7% for O157:H7 and from 4.6 to 55.9% for non-O157 STEC
serotypes. Although sanitary procedures during processing are effective in
reducing STEC on carcasses (Elder, Keen et al. 2000), the organisms were still
detectable from post-processing carcasses, retail products in supermarkets and
fast food restaurants, with the prevalence rates of 0.01-43.4%, 0.1-54.2% and
2.4% respectively for O157:H7, and 1.7-58.0%, 3.0-62.5% and 3.0% respectively
for non-O157:H7 (Hussein 2007).

23

Serogroup O91, although seldom reported in outbreaks or HUS cases in
the US, is among the five serogroups most frequently associated with human
illnesses and outbreaks in Europe and is the most prevalent serogroup among
adult patients in Germany (Mellmann, Fruth et al. 2009). A survey (Werber,
Beutin et al. 2008), that reviewed samples collected from 1996 to 2007 in
Germany, ranked O91 as the second most prevalent serogroup (6% of 448
isolates from foods) in food samples and the fourth among isolates from patients
(10% of 1447 isolates). Interestingly, in the same study, O91 was the only
serogroup frequently isolated from both food samples and patients (Werber,
Beutin et al. 2008). Within the serogroup, O91:H21 is the only serotype
implicated in HUS cases (Oku, Yutsudo et al. 1989; Werber, Beutin et al. 2008).
Genetic analysis of an O91:H21 isolate revealed the presence of a Stx2 variant,
Stx2vh, which is considered to be an indicator of potential severe consequences
in human infection (Zweifel, Giezendanner et al. 2010). Oral infection in a
streptomycin-treated mouse model also revealed the high virulence of this
serotype, with two O91:H21 isolates having LD50 less than 10 bacteria (Lindgren,
Melton et al. 1993).
An enhanced understanding of heterogeneous shedding patterns of STEC
by cattle and factors that might influence shedding magnitude and duration could
help develop strategies to reduce the level of STEC entering food production
systems, and, therefore, control infections resulting from the consumption of
STEC contaminated foods. Seasonal shedding patterns have been well
documented previously. Reports indicate that the prevalence of STEC in cattle
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populations commonly reach the highest rates in the summer and decreases to
very low rates during the winter (Hancock, Besser et al. 1997; Pradel, Livrelli et al.
2000; Barkocy-Gallagher, Arthur et al. 2003; Miller, Beasley et al. 2003). This is
consistent with the seasonal patterns of STEC infection in human, where greater
incidence of illnesses occurs during the late summer months (Rangel, Sparling et
al. 2005; Friesema, J et al. 2010). However, the mechanisms of seasonality are
not clear. Among various factors distinct between seasons, one study (Edrington,
Callaway et al. 2006) showed positive correlation between day length and
O157:H7 prevalence in cattle feces (r = 0.67; P = 0.0009) as well as between
ambient temperature and O157:H7 prevalence (r= 0.43; P = 0.05).
Previously in our experiment, a study was conducted to determine the
effect of controlled warm and cool ambient temperature on shedding properties
of STEC O157:H7 and O91:H21 in calves. Holstein steers were assigned to an
oral inoculation of O157:H7 (n=4) or O91:H21 (n=4). Within calves inoculated
with the same strain, half were housed under a cool temperature regimen (12h at
18oC; 12h at 15oC) and the other half under a warm temperature regimen (12h at
32oC; 12h at 27oC). The concentration of each inoculated strain contained in
feces was examined every two days for up to 2 weeks PI. Sorbitol McConkey
agar (SMAC) containing 50ug/ml nalidixic acid was used to recover strains from
fecal samples, since both strains are resistant to this antibiotic. However, after 10
days PI, isolates recovered in fecal samples from some calves were genetically
inconsistent with initial challenge strains, and these interfering bacteria were not
distinguishable from the challenge strains via colony morphometrics. Similar
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contaminating bacteria were also isolated from candidate calves originally
intended for a second trial but that had not been subjected to inoculation. Four
dominant types of colonies with distinct phenotypes (color and size of the colony)
were observed among the contaminating bacteria from feces of candidate calves
on the selective SMAC agar. Two colonies of each phenotype were tested for
their identity based on the results of 20 biochemical reactions included on the
API 20E strip (BioMerieux Vitch, Inc., Hazelwood, MO). According to the
interpretation of API 20E database, majority of the tested colonies (6 colonies
belonging to 3 phenotypes) were characterized as E. coli with very high
identification and the remaining two colonies were characterized as E. coli with
great likelihood but low selective identity. Using the NARMS CMV1AGNF panel
(Trek Diagnostics, Cleveland, OH), all four phenotypes of colonies demonstrated
multi-drug resistance (Table 1), which confirmed the difficulty for the use of
antibiotic resistance markers.
Thus, to address what appear to be significant shortcomings of antibiotic
resistance markers for STEC challenge studies where the presence of multi-drug
resistant indigenous bacteria might confound such, the objective of this study
was to develop more effective markers suitable for research on STEC using
animal models or environmental samples. Chromosomally-integrated luxCDABE
and plasmid-borne GFP markers of STEC were developed and evaluated both in
vitro in terms of growth cost, stability, and other relevant aspects, and in
O91:H21 shedding experiment to determine their feasibility in cattle challenge
experiments.
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Table 1. Four antibiotic resistance profilesa displayed by four dominant phenotypes of interfering fecal isolates from
candidate calves prior to inoculation
1
Cefoxitin
Amikacin
Chloramphenicol
Tetracycline
Ceftriaxone
Amoxicillin/Clavulanic Acid
Ciprofloxacin
Gentamicin
Nalidixic acid
Ceftiofur
Sulfisoxazoleb
Trimethoprim/sulfamethoxazole
Kanamycin
Ampicillin
Streptomycin

4 (S)
16 (S)
>32 (R)
>32 (R)
≤0.25 (S)
8/4 (S)
>4 (R)
4 (S)
>16 (R)
0.5 (S)
>256
>4/76 (R)
>64 (R)
>32 (R)
64 (R)

2
4 (S)
2 (S)
32 (R)
>32 (R)
≤0.25 (S)
8/4 (S)
>4 (R)
4 (S)
>16 (R)
0.5 (S)
>256
>4/76 (R)
>64 (R)
>32 (R)
64 (R)

3

4

4 (S)
2 (S)
32 (R)
>32 (R)
≤0.25 (S)
8/4 (S)
>4 (R)
1 (S)
>16 (R)
0.5 (S)
>256
>4/76 (R)
>64 (R)
>32 (R)
>64 (R)

16 (I)
2 (S)
>32 (R)
>32 (R)
≤0.25 (S)
2/1 (S)
0.5 (S)
8 (I)
>16 (R)
0.5 (S)
>256
>4/76 (R)
>64 (R)
>32 (R)
>64 (R)

S – Susceptible, I – Intermediate, R – Resistant. Susceptibility of isolates was determined by Minimum Inhibitory
Concentrations (ug/ml) of each antibiotic. Antibiotics contained on NARMS plates were all listed here.
b
256ug/ml is the highest concentration for sulfisoxazole on NARMS plate. Based on CLSI standard that MIC breakpoint for
resistance to sulfonamide antibiotics is 512ug/ml, sulfisoxazole resistance cannot be determined.
a
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MATERIALS AND METHODS
Bacterial strains
STEC O91:H21
The STEC O91:H21 strain used in this study was provided by our
collaborator, Dr. Nora Lia Padola of the Faculty of Veterinary Sciences,
University Nacional del Centro PBA, Tandil, Argentina. It was originally isolated
from a cattle farm in Argentina and was confirmed to harbor stx2 (shiga toxin
type II), saa (autoagglutinating adhesin) and ehxA (enterohemolysin) genes.
Besides the resistance to nalidixic acid, the strain was also confirmed to be
resistant

to

trimethoprim

and

erythromycin

with

minimum

inhibitory

concentrations (MIC) of 125ug/ml and 250ug/ml, respectively. The two antibiotics
were previously used in combination with nalidixic acid in SMAC selective
medium for additional selection efficiency with the highest concentrations at
50ug/ml, 100ug/ml, respectively; however the purpose of eliminating indigenous
bacteria was not well satisfied.

Construction of bioluminescent E. coli O91:H21
Construction of a bioluminescent E. coli O91:H21 was achieved by
conjugation followed by a suicide plasmid delivery of the luxCDABE operon into
the recipient strain and transposon mutagenesis. The suicide plasmid carried by
the donor strain E. coli S17/pUT mini-Tn5 luxCDABE Km2 (a gift from Dr. David
Piwnica-Worms, Washington University School of Medicine, St. Louis, MO)
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contained the luxCDABE operon engineered from Photorhabdus luminescens
and a kanamycin resistance gene downstream of luxE gene, which together are
flanked by mini-Tn5 transposon components (Winson, Swift et al. 1998). The
O91:H21 isolate from Argentina was used as the recipient strain. Conjugation
followed the procedure described previously (Winson, Swift et al. 1998), with
some modifications. Briefly, cells harvested from overnight cultures were gently
washed twice to remove antibiotic residues and then resuspended in 1/10 of
original amount of LB broth (Fisher Scientific, Fairlawn, NJ). Donor and recipient
cells were well mixed in equal ratio and spot inoculated on LB agar plates. Upon
inoculation at 37°C for 7 h, cells were scraped from LB plates and spread on LB
agar plates containing 50 ug/ml nalidixic acid and 50 ug/ml kanamycin for the
selection of transconjugants. Three isolates showing the brightest light visible by
naked eye in the dark were saved as candidates and were designated as E. coli
O91:H21/Lux1, Lux2 and Lux3. Along with these isolates, 7 other isolates with
less intense bioluminescence were also preserved. The absence of the transfer
plasmid was confirmed for all isolates by a susceptibility test to 100 ug/ml
ampicillin (the ampicillin resistance gene is located on the transfer plasmid, but
outside of mobile element) and plasmid extraction followed by electrophoresis.

Construction of GFP-transformed E. coli O91:H21
Construction of the GFP-transformed E. coli O91:H21 was achieved
through the transformation of a pGFP vector (Clontech Laboratories, Inc., CA)
containing ampicillin resistance gene into competent O91:H21 cells prepared via
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the Calcium Chloride method (Mandel and Higa 1970; Cohen, Chang et al. 1972).
Successful transformation conferred growth ability on LB agar containing 100
ug/ml ampicillin and 50 ug/ml nalidixic acid, along with emission of visible strong
green light when colonies were exposed to UV light in the dark.

In vitro validation of Lux- and GFP- constructs
API 20 E test
API 20 E strip (BioMerieux Vitch, Inc., Hazelwood, MO) was used
according to the manufacturer’s instructions to determine whether the integration
of luxCDABE affected the biochemical reactions of the original organism included
on the strip. The color of each well representing each biochemical reaction was
compared between the three lux-constructs and the original O91:H21 strain.

Confirmation of essential genes by multiplex PCR
Random transposon integration may result in the disruption of a gene
conferring STEC virulence. To ensure against such, all three Lux-integrated
constructs were tested by two multiplex PCRs (M-PCR) for the presence of
genes stx2, saa and ehxA, as well as genes wbsD and fliCH21 that represent
antigens unique to serotype O91:H21. Primers used in all PCR reactions of this
study are listed in Table 2. Total DNA was prepared by boiling cell pellets,
harvested from overnight culture in sterile ddH2O, for 10 min followed by
centrifugation at 13,000 rpm. Supernatant containing whole genomic DNA was
immediately used for PCR. The M-PCR conditions for the detection of stx2, saa

30

and ehxA genes were: 1) 1 cycle of 94°C for 5 min; 2) 35 cycles of 94°C for 30 s,
57°C for 1 min and 72°C for 1 min 30 s; 3) 1 final cycle of extension at 72°C for 5
min. The conditions for wbsD and fliCH21 amplification were: 1) 1 cycle of 94°C
for 5 min; 2) 35 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 30 s; 3) 1 final
cycle of 72°C for 7 min. Each reaction included 12.5 ul GoTaq® Green Master
Mix, 2X (Promega, Madison, WI), 1 ul of each primer (5 pmol/ul), 1 ul template
DNA and 5.5 ul sterile ddH2O. All reactions were conducted in a Mastercycler
Gradient thermocycler (Eppendorf, Westbury, NJ).

Identification of transposon insertion site
In order to better characterize the three Lux-integrated constructs, a
Touchdown PCR previously described (Levano-Garcia, Verjovski-Almeida et al.
2005) was used to identify transposon insertion sites in the chromosome. A
hybrid-consensus degenerated primer, called HIB17, targeting unknown regions
and an outward facing primer Kan specifically targeting the 3’ end of kanamycin
resistance gene located immediately downstream of luxE were used. PCR
reaction conditions were as previously described, except GoTaq® Green Master
Mix (Promega, Madison, WI) was used. After separating PCR products on the gel,
products exhibiting the brightest bands were purified by QIAquick Gel Extraction
Kit (Qiagen, Hilden, Germany) and sequenced by the Molecular Biology
Resource Facility at The University of Tennessee (Knoxville, TN).
Identical sequence results were found between O91:H21/Lux2 and Lux3,
indicating they were from the same clone. Sequencing the PCR product of
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O91:H21/Lux1 was not successful. Therefore, only O91:H21/Lux2 was used in
the following experiments. Alignment of the sequence of O91:H21/Lux2 with the
complete genome sequence of Escherichia coli CFT073 revealed that the
transposon insertion site was approximately next to the yihM gene. A new primer,
Yih, was designed for targeting the 5’ end of yihM gene. The PCR product
amplified by primer yih and luxE (Flentie, Qi et al. 2008) targeting 3’ end of luxE
gene was sequenced and the exact transposon insertion site was determined by
localization of the conserved I-end sequence (5’-CTGTCTCTTGATCAGATCT-3’)
of mini-Tn5 transposon.

Growth curves
Growth curves were measured for E. coli O91:H21, O91:H21/Lux2 and
O91:H21/GFP constructs. Strains were grown to mid-log phase (OD600≈0.8) with
very similar OD600 values (±0.01). Each culture was diluted 1:100 in fresh LB
broth, and incubated at 37°C with shaking at 200 rpm. Growth was measured in
terms of OD600 value of the culture every hour for the first 10 hours and every 2
hours for the next 10 hours. The experiment was conducted in duplicate.
Growth data of three strains were analyzed using Graphpad Prism
software (GraphPad Software, Inc., La Jolla, CA). Growth curves were generated
using OD600 values according to the modified nonlinear Gompertz model (Fig. 1)
(Zwietering, Jongenburger et al. 1990; Romano, Molla et al. 2009) and the bestfit values of the parameters in Gompertz equation, including maximal growth rate
(μmax), lag time (λ) and initial bacterial number (N0) and the difference between
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final and initial bacterial number (A) were compared between three groups using
F-test.

In vitro stability assay
The stability of integrated luxCDABE and transformed GFP gene was
tested by subculturing two O91:H21 constructs in liquid medium without antibiotic
selection. For each passage, a 20ul aliquot from the previous passage was
inoculated into 5 ml of fresh LB broth without antibiotics. The culture was passed
after every 12 h for up to 60 passages (approximately 2160 generations if the
generation time of our E. coli strains was 20 min), unless a significant loss of the
marker gene was observed.
Samples from each subculture were tested on LB agar containing
appropriate antibiotics to detect the presence of luminescence-negative or green
fluorescence-negative isotypes during the first 10 passages and from every five
subcultures thereafter. To identify luminescence-negative colonies on LB agar
plates, a FluorChem® imaging system (Alpha Innotech Corp, San Leandro, CA)
was used. Two images were taken for each plate with one taken under artificial
white light (Fig. 2A) and the other in the dark (Fig. 2B). Luminescence-negative
colonies which were only displayed in the image taken with light were further
subject to M-PCR for their isotypes to determine whether they were the isogenic
O91:H21 without bioluminescence marker. The presence and percentage of
green fluorescence-negative colonies in subculture population were determined
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by exposing colonies to UV light, and fluorescence-negative colonies were tested
for the isotypes to ensure the confidence of stability results.

Animal experiments
Calves, housing and treatment
The shedding experiment of wild type O91:H21 was conducted separately
from those of luxCDABE and GFP-marked strains and was a part of the previous
shedding experiment where nalidixic acid resistance marker was used for
identifiable recovery.
For the shedding experiment of luxCDABE and GFP-marked strains, eight
Holstein steers with average body weight of 85.6±8.1 kg were obtained from a
private commercial dairy farm in Kentucky and were transported to and
maintained in The Joe Johnson Animal Research and Teaching Unit (JARTU) of
the UT AgResearch East Tennessee Research and Education Center near the
Knoxville campus. Calves were assigned to one of four identical BSL2
containment rooms, with two calves maintained in each room separated by metal
pens to avoid physical contact. Each pen was equipped with an independent
water system and a feeding trough by which animals were provided ad libitum
access to feed and water. Animal rooms were cleaned with water via large
delivery volume hose every day.
Following 5 days of acclimation to the rooms, four calves from two rooms
received the O91:H21/Lux2 challenge strain and the four calves in the other two
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rooms received the O91:H21/GFP. To prevent cross-contamination, coveralls
and gloves were changed and boots disinfected in a boot wash between rooms
of the two challenge strains.

Bacteria preparation and inoculation
Prior to inoculation into the calves, both the luxCDABE-integrated and
GFP-transformed O91:H21 constructs were tested for their ability to survive in
bovine feces via stab inoculation of the organisms in unsterile feces. After
overnight incubation at 37oC, the two strains were successfully recovered with
different selective media, including LB containing 50 ug/ml kanamycin and 50
ug/ml nalidixic acid for lux-construct and LB containing 100 ug/ml ampicillin and
50 ug/ml nalidixic acid for GFP-construct.
One loopful of O91:H21/Lux2 and O91:H21/GFP cultures from the original
stock was inoculated into 100 ml LB broth and incubated overnight at 37°C.
Bacterial concentrations were determined via serial dilution and plating on LB
agar. Enumeration revealed a concentration of 6.5 x 10 8 CFU/ml for
O91:H21/Lux2 inoculum and 2.3 x 108 CFU/ml for O91:H21/GFP.
Twenty milliliters of bacterial culture was orally administered to each calf
through an esophageal feeding tube. With the tube still in position in the animal,
an additional 200ml of sterile LB broth was applied to wash residual bacteria in
the tube into the calf.

35

Sample collection
Fecal samples were collected on the day calves arrived, immediately
before inoculation and every two days PI for a period of two weeks. Fresh fecal
samples were obtained by rectal palpation. In cases where animals were seen to
defecate during pen cleaning during a sampling period, fresh fecal material was
immediately collected from the evacuated stool on the floor, avoiding touching
the tube to contaminating surfaces or older manure. Five to ten grams of each
sample were collected using a sterile 50ml plastic tube, and transported to the
laboratory immediately in ice. At the end of the trial, all animals were euthanized
via IV injection of pentobarbital sodium (Beuthanasia D, Schering-Plough Animal
Health, Union, N.J) delivered at 10 ml per 100 lb of animal body weight. Samples
were collected from five locations of intestine, including the duodenum, ileum,
cecum, and descending colon and rectum. All animal and biosafety protocols
were approved by the University of Tennessee Institutional Animal Care and Use
Committee, and BioSafety Committee, respectively.

Bacterial Enumerations
Approximately two grams of each manure sample was diluted to 20%
(wt./vol.) in 1x phosphate buffered saline (PBS) and well mixed via vigorous
vortexing. Mixtures were maintained at room temperature for 30min for
precipitation of solid matter. The supernatant was then serially diluted, and 100ul
of each dilution was spread on LB plates containing 50 ug/ml nalidixic acid and
one other antibiotic (50 ug/ml kanamycin for O91:H21/Lux2 treatment and 100
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ug/ml ampicillin for O91:H21/GFP treatment). The detection limit by the plating
procedure described above is 50 CFU/g feces.
In practice, counting the luminescent colonies by naked eye in the dark
posed some difficulty, especially when the number of colonies was large. To
overcome

this

inconvenience,

the

previous

mentioned

method

using

FluorChem® imaging system (Alpha Innotech Corp, San Leandro, CA) was used
for enumeration. Bioluminescent colonies were enumerated from the image
taken in the dark. Additionally, both the bioluminescence-positive and negative
colonies were selected for M-PCR testing of isotypes to determine the
confidence of enumeration results. For a convenient separation of the two types
of colonies, especially on a cluttered plate, the two images of each plate taken by
FluorChem® imaging system were superimposed using the Overlay function in
AlphaEase® FC software (Alpha Innotech Corp, San Leandro, CA) to provide the
exact position of each bioluminescent colony (Fig. 1C). Green fluorescent
colonies were enumerated by exposing colonies to UV light.

Colony confirmation
DNA prepared directly from individual colonies was subjected to M-PCR
for the presence of stx2, saa and ehxA genes. Within the group receiving luxO91:H21, up to 20 bioluminescent colonies from each sample were selected for
M-PCR to confirm the isotype. Bioluminescent-negative colonies from SMAC
plates containing 50 ug/ml nalidixic acid and LB plates containing both nalidixic
acid and kanamycin were also tested for the isotype to determine whether the
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loss of luxCDABE operon occurred during the experiment. Additionally,
bioluminescent-positive colonies from LB plates without antibiotics were also
tested to determine whether there’s a chance for the mini-Tn5 transposon to
jump to and generate luminescence in co-habitating bacteria.
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Table 2. Primers used in this study
Primer

DNA Sequence (5’ to 3’)

Stx2-F

CTTCGGTATCCTATTCCCGG

Stx2-R

CTGCTGTGACAGTGACAAAACGC

Saa-F

CGTGATGAACAGGCTATTGC

Saa-R

ATGGACATGCCTGTGGCAAC

EhxA-F

GGTGCAGCAGAAAAAGTTGTAG

EhxA-R

TCTCGCCTGATAGTGTTTGGTA

WbsD-F

GCTGACCTTCATGATCTGTTGA

WbsD-R

TAATTTAACCCGTAGAATCGCTGC

FliCH21-F

ACAGGATAAAGATGGCAAACAAGTT

FliCH21-R

GCAGCCACTGCAAGCTTAGTT

HIB17

Product
size (bp)

Reference

516

(Blanco, Blanco et al. 2004)

119

(Paton and Paton 2002)

1551

(Schmidt, Beutin et al. 1995)

291

(Perelle, Dilasser et al. 2002)

108

(Auvray, Lecureuil et al. 2008)

CGGAATTCCGGATNGAYKSNGGNTC

N/A

(Levano-Garcia, Verjovski-Almeida
et al. 2005)

Kan

CGAGCTCGAATTCGGCCTAG

N/A

(Flentie, Qi et al. 2008)

LuxE

TGAGGATGAAATGCAGCGTA

N/A

(Flentie, Qi et al. 2008)

Yih

CGACGGCTTCGTCAATAGAT

N/A

This study
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RESULTS
Characterization of luxCDABE-integration and GFP-transformed
STEC O91:H21
The integration of luxCDABE operon apparently did not disrupt the genes
conferring the production of O91, H21, Stx2, Saa or enterohemolysin, as PCR
products of these genes were of identical sizes between the otherwise isogenic
STEC O91:H21 with and without luxCDABE. No significant color difference was
observed from each well of the API 20e strip (Fig. 3), suggesting the transposon
integration and the production of luciferase and its substrates did not impact the
biochemical reactions included in API 20e system.
The transposon integration site on the chromosome was further
determined using a previously mentioned touchdown PCR procedure (LevanoGarcia, Verjovski-Almeida et al. 2005). According to the E. coli strain CFT073
complete genomic sequence annotation, the luxCDABE operon was integrated at
nucleotide 4,586,515 (Fig. 4A and 4B). The integration site was 27 nucleotides
before the stop codon of gene yihL, which is a putative transcriptional regulator
(Welch, Burland et al. 2002) and may be involved in the transcription of
downstream gene yihM coding a putative sugar phosphate isomerase (Welch,
Burland et al. 2002). Currently, little is known about the role of gene yihL or yihM
in E. coli. Although another two genes, yihO and yihQ, within the yih operon of
Salmonella were involved in O-antigen capsule assembly and translocation
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(Gibson, White et al. 2006), it is not known whether the role of yihL and yihM
genes within the yih operon of E. coli is related to similar functions as well.
Growth curves of O91:H21 strain and two constructs with luxCDABE and
GFP markers were compared via the comparison of parameters in the Gompertz
equation. No significant difference was found in the maximum growth rate
(P=0.5446), lag time (P=0.3267), initial OD600 value (P=0.3875) and maximum
OD600 difference (P=0.3487) among three groups, suggesting the fitness of luxmarked and GFP-marked constructs was not affected by the introduction of
chromosome-integrated luxCDABE and plasmid-borne GFP markers in pure
culture.
The strain containing the transposon integrated luxCDABE marker was
subcultured in liquid medium for 60 passages. During this in vitro stability assay,
only one bioluminescence negative colony was observed at the eighth passage.
All other colonies were tested positive for bioluminescence with similar intensity
and resistance to kanamycin.
In contrast, the in vitro stability assay indicated the plasmid-bearing GFP
marker had low stability in our O91:H21 strain. GFP-negative colonies were first
detected at the fourth passage, comprising approximately 0.63% of the
population. After that, the percentage of GFP-negative isotypes in the population
of each subculture started to increase slowly to 3.45% at the eighth passage, and
then increased dramatically to 54.21% at the tenth passage. Therefore, the
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approximate half-life of this GFP-marked O91:H21 in liquid medium was 10
passages.

Fecal shedding of STEC O91:H21 in experimentally infected
calves
All calves receiving either the luxCDABE-marked, GFP-marked or wild
type O91:H21 remained physically healthy with normal appetites throughout the
two-week shedding experiment. Within all three treatment groups, 1 to 2 calves
of each group were observed exhibiting non-bloody diarrhea intermittently. No
bloody diarrhea was observed.

Wild type O91:H21
Four calves were initially used to assess the fecal shedding pattern of wild
type O91:H21. Due to the presence of sorbitol-fermenting and nalidixic acid
resistant indigenous bacteria in one calf at the beginning of the experiment, the
data recorded for this individual were not used.
As showed in Fig. 5, the number of wild type O91:H21 shed in bovine
feces was 1.4 x 103, 6.4 x 103 and 1.8 x 104 CFU/g, respectively, in three calves
at day 2 PI (first sampling point after inoculation). One calf shed the organism
intermittently, however it was not known whether the organism was absent from
cattle intestine at day 10 PI where the fecal sample was tested negative of the
organism. Only one calf was continuously tested positive of the organism for a
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two-week period, while the remaining calf continuously shed the organism for 12
days and was tested negative of the organism in feces at day 14 PI. As
mentioned previously, in two of the three calves that received wild type O91:H21,
post-experiment M-PCR analysis showed the presence of indigenous bacteria,
which was recovered from fecal samples collected after day 10 PI, on selective
plates. Because these interfering organisms were unable to be separated from
challenge strain on SMAC plate containing 50ug/ml nalidixic acid, the
enumeration results would include the number of these organisms and, therefore,
could not accurately reflect the shedding magnitude.
Contents from four different parts of the bovine intestine, in addition to the
feces from rectum, were collected at the end of the experiment and tested for the
presence of O91:H21 (Fig. 7). The organism was not isolated from duodenal
contents of any calves. Two calves, that were tested positive for the organism in
feces at day 14 PI, were also tested positive for the organism in the contents of
cecum and colon. The organism also was found in the ileum of one of the two
calves, while ileal content from the other calf was not available during the
sampling. Although the organism was not detected in feces from the remaining
calf, the organism was recovered from ileum and colon. As mentioned above, the
estimation of concentrations of the organism in intestinal contents of two calves
was confounded by the presence of indigenous bacteria with nalidixic acid
resistance and was not precise.
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LuxCDABE-marked O91:H21
As showed in Fig.8, the fecal count of luxCDABE-integrated O91:H21 was
1.2 x 103, 1.2 x 103, 8.7 x 103 and 1.3 x 104 CFU/g, respectively among four
calves at day 2 PI. Among the four calves, two with lower initial shedding levels
became undetectable at day 12 and 14 PI, respectively, while the shedding
levels in the remaining two calves with higher initial shedding levels decreased to
5.8 x 102 and 8.7 x 102 CFU/g, respectively at day 14 PI.
The screening for bioluminescence-positive O91:H21 in contents of
duodenum, ileum, cecum and descending colon of all calves at day 14 PI (Fig. 9)
showed no such bacteria were detected in duodenal contents collected from all
calves. In the two calves that maintained detectable fecal counts at day 14, the
organism was recovered from the contents of the other three parts of the GIT,
with the concentrations of 3.0 x 102 and 5.0 x 101 CFU/g in ileum, 6.3 x 102 and
1.3 x 103 CFU/g in cecum, 1.0 x 103 and 1.0 x 103 CFU/g at descending colon,
respectively. In the other two calves that did not shed detectable levels of the
organism in feces at day 14, the organism was still detectable by plating from the
contents of cecum and descending colon with concentrations at approximately
5.0 x 101 CFU/g.
During the two-week shedding experiment, selected luminescencepositive and negative colonies recovered from each fecal samples were tested
for isotype to assess the stability of the marker under conditions related to the
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presence of indigenous gut microflora. A total of 242 bioluminescence-positive
and 81 bioluminescence-negative colonies from LB agar containing 50 ug/ml
nalidixic acid (resistance feature of lux-marker host strain) and 50 ug/ml
kanamycin (resistance feature carried with luxCDABE marker) as well as 71
bioluminescence-negative colonies resistant only to nalidixic acid were tested. All
the positive colonies were confirmed as the lux-marked O91:H21 inoculum while
all the negative colonies belonged to indigenous microflora, suggesting that the
luxCDABE marker was stably maintained in host strain and could efficiently
distinct marked strain from indigenous bacteria and, therefore, ensured the
reliability of the enumeration results of the cattle shedding experiment.

GFP-marked O91:H21
Stability of the plasmid-bearing GFP marker was poor during the
assessment of fecal shedding pattern of this construct in calves. No GFP-positive
colony was recovered from fecal samples of any calves receiving GFP-marked
O91:H21 throughout the sampling period. However, isogenic GFP-negative
O91:H21 isolates were detected from all four calves using SMAC agar containing
50 ug/ml nalidixic acid and confirmed by M-PCR analysis, indicating the
challenge strain had successfully localized in calf intestine or intestinal contents
but the plasmid carrying the GFP marker was not well maintained in the construct
in the presence of indigenous microflora and other conditions within the intestine.
Although the estimation of shedding magnitude could be very inaccurate as

45

confounded by the presence of indigenous bacteria exhibiting sorbitol fermenting
and nalidixic acid resistant features, our results showed that two of the four
calves shed the O91:H21 strain for the entire two-week sampling period, while
the other two did not shed detectable levels of the organism at day 6 and day 10
PI, respectively.
No O91:H21 was recovered from the duodenal contents in calves that
received GFP-marked O91:H21. Contents of the ileum, cecum and descending
colon tested positive for O91:H21 in the two calves with fecal shedding for at
least 14 days; however, only the contents of the cecum and descending colon
were positive for the organism in the calf that shed the organism for at least 10
days. No O91:H21 was recovered from intestinal contents of the remaining calf.
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DISCUSSION
The shedding magnitude and duration of STEC in ruminant feces is an
important topic, particularly because of the relevance to various STEC
contamination sources and significant numbers of human infections. However,
the traditional way of using antibiotic resistance markers for the identifiable
recovery of the inoculated STEC strains from cattle feces can be interfered by
indigenous microflora exhibiting similar antibiotic resistance patterns, as
observed in our previous study. In this study, a chromosomally-integrated
luxCDABE based bioluminescence marker system was developed in STEC
O91:H21 and showed reliability for the detection and enumeration of STEC and
was used to monitor the fecal shedding of O91:H21 for a two-week period. On
the other hand, a plasmid-borne green fluorescent protein marker showed poor
stability in the same O91:H21 host strain and is not recommended for long term
experiments without appropriate antibiotic selection (assuming such is possible).
Several recent studies (Englen, Fedorka-Cray et al. 2005; Fluckey,
Loneragan et al. 2007; Schierack, Romer et al. 2009) have reported a high
proportion of isolates, including E. coli, Salmonella, and Campylobacter, from
fecal microflora of farm animals were resistant to at least one antibiotic, with a
portion of the isolates exhibiting resistance to multiple antibiotics. For many
shedding experiments, the traditional way of using antibiotic resistances as
markers for the recovery of marked challenge organisms from animal or
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environmental samples requires rigorous pre-inoculation screening to ensure the
test animals are free of bacteria resistant to selective antibiotics; otherwise, the
indigenous microflora exhibiting antibiotic resistance may confound the detection
and enumeration of the marked challenge organisms using antibioticsupplemented selective media. In some circumstances, as observed in the
shedding experiment of wild type O91:H21 in our previous study, animals
confirmed free of interfering bacteria prior to inoculation may obtain such bacteria
later during the experiment from environment, feed and water, which could
greatly confound enumeration results and affect the entire experiment.
Among STEC, specially designed selective or differential media are
available for typical O157:H7 based on its unique phenotypes including delayed
or defective sorbitol fermentation and negative β-glucuronidase (GUD) activity.
The use of such media could help enhance the selection of this organism from
animal feces, as reported in several studies (Kudva, Hatfield et al. 1995; Sheng,
Davis et al. 2004). As for non-O157 STEC, few effective selective media are
currently available due to the high genetic diversity of these organisms. Some
commonly-used selective media for non-O157 STEC, such as MacConkey (MAC)
or SMAC agar, even in combination with selective antibiotics, may not provide
adequate discrimination between indigenous resistance bacteria and antibiotic
resistance marked challenge organisms, as observed in this study.
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The bioluminescence marker and green fluorescence marker, due to their
rare phenomenon in livestock microflora, have the potentials to complement the
inadequate selection of antibiotics and/or selective media in shedding experiment.
To fulfill the purpose of using the marked strain to assess its shedding
pattern in animal feces, where it would be challenged by competition from
indigenous microflora as well as other potentially stressful conditions, the fitness
of the construct should match the growth behavior of the host strain and not be
affected by the introduction of marker systems. Based on the result that no
significant growth difference was detected between the wild type and its luxconstruct in liquid medium, it is assumed that the expression of luxCDABE
operon and the production of luciferase and its substrates did not add much
metabolic burden on the host strain. Similar low fitness costs were also reported
for similar chromosomal bioluminescence markers in Salmonella Typhimurium
(Flentie, Qi et al. 2008) and Pseudomonas fluorescens (Amin-Hanjani, Meikle,
1993). The introduction of plasmid-borne markers, on the other hand, may affect
the fitness of the construct, partly due to the increased expression of the higher
copy of marker genes (Amin-Hanjani, Meikle, 1993). However, such was not the
case in the plasmid-borne GFP marker constructed in this study.
Stability is another important criterion for the evaluation of a reliable
marker system. The use of plasmid-borne bioluminescence markers was
suggested, requiring additional selection pressure to maintain the plasmid in long
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term studies (Ritchie, Campbell et al. 2003), otherwise, as showed in one such
construction in Pseudomonas fluorescens (Amin-Hanjani, Meikle, 1993), the luxmarker may have a half-life as short as 11.5 passages during subculturing in
liquid media. In contrast, the chromosomally-integrated luxCDABE marker
constructed by mini-Tn5 transposon mutagenesis in this study showed high
stability in the host strain both in vitro and cattle shedding experiment. Although
the loss of bioluminescence was observed once during the subculturing in a
liquid medium, probably due to deletion or excision of the transposon, such was
not noted during the two-week shedding experiment in cattle.
Compared to bioluminescent markers, the cell light output by GFP
markers is more closely dependent on the copy number of the gfp gene;
therefore, plasmid-bearing GFP markers were frequently used to track the
survival

of

marked

organisms

in

different

environmental

samples

(Himathongkham, Bahari et al. 1999; Burnett, Chen et al. 2000; Gagliardi and
Karns 2002; Wachtel, Whitehand et al. 2002; Franz, van Diepeningen et al.
2005). No loss of GFP marker was reported in these studies and, in one
experiment (Franz, van Diepeningen et al. 2005), STEC O157:H7 containing a
pGFP vector (a plasmid coding GFP) was detected for at most 133 days in cattle
manure. In the current study, the same pGFP vector was used to mark O91:H21
strain, however, the marker showed poor stability both in vitro and in the cattle
shedding experiment. Therefore, the plasmid-bearing GFP marker is not

50

recommended for long term studies, unless antibiotic selection can be
incorporated into the research methods.
During the shedding experiment, the discrimination using bioluminescence
marker greatly complemented the inadequate selection of antibiotics. Interfering
indigenous bacteria with similar resistance pattern (nalidixic acid and kanamycin
resistance) was recovered on antibiotic-supplemented LB plates most of the time
during the shedding experiment, but the use of bioluminescence marker could
easily separate them in the dark. And according to the post-experiment M-PCR
analysis, the discrimination was accurate and the enumeration results were
reliable. Meanwhile, the enumeration of bioluminescent colonies only required an
imaging system that can take pictures in the dark with extended exposure time.
Such imaging systems can be easily found in most of the molecular biology
laboratories.
One potential benefit of using bioluminescent markers is the estimation of
vital cell concentration via the measurement of light intensity. Chromosomebearing bioluminescent markers have the advantage of reflecting the number of
light-emitting cells with high accuracy (Amin-Hanjani, Meikle, 1993). Therefore,
there’s a potential to develop a non-extractive and high-throughput enumeration
method for STEC shedding experiments. However, compared to plasmid-bearing
markers, the chromosome-bearing lux-markers are limited in low copy number of
lux genes in one cell and, therefore, have higher minimum detection
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concentration of the organisms (Siragusa, Nawotka et al. 1999; Ritchie,
Campbell et al. 2003). Previous studies have reported that minimums of 1.5 x 104
CFU/g of chromosomal lux-marked O157:H7 in soil (Ritchie, Campbell et al.
2003) and 4.2 x 103 to 8.0 x 104 CFU/ml of chromosomal lux-marked Salmonella
enterica in clear medium (Howe, Karsi et al. 2010) were required for the
detection of luminescence using luminometry. Later in this study, the minimum
detection concentration of our lux-construct was also measured according to the
method described previously (Howe, Karsi et al. 2010) and a minimum of
approximately 4.5 x 104 CFU per gram feces was needed. Such detection limit
could not fulfill the STEC shedding study in cattle as concentrations of the
organism in fecal samples collected during most of the sampling points were
below or around the minimum detection level. Further studies are needed. The
construction of a chromosomal luxCDABE marker with multi-insertion or the
development of a strong promoter for the expression of lux genes could increase
detection sensitivity and may be considered for future improvement of this
marker system.
To our knowledge, our study was the first study to report the shedding
pattern of STEC O91:H21 in cattle feces. Compared to the fecal shedding pattern
of O157:H7 by calves receiving the same dose, the shedding magnitude of our
O91:H21 strain was relatively lower: 1.2 x 103 to 1.8 x 104 CFU/g in O91:H21
shedding compared to 7.9 x 103 to 4 x 106 CFU/g in O157:H7 shedding at day 2
post inoculation (Brown, Harmon et al. 1997); meanwhile the highest shedding
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magnitude of O157:H7 by individual calves could reach as high as approximately
108-109 CFU/g (Cray and Moon 1995), such high levels were not observed here
and the highest value in this study was 9.3 x 10 4 CFU/g. The explanation for the
difference of shedding levels between these two serotypes was not clear. One
possible explanation is the variety in fitness of two strains when in the presence
of indigenous intestinal microflora. Additionally, because of the different diets,
animal sources, husbandry methods, etc., some intestinal physiological
conditions impacting bacteria growth and proliferation could differ between the
calves used in different experiments (Widiasih, Ido et al. 2004). A greater
shedding magnitude of O157:H7 suggests a higher chance to contact the
organism; however this doesn’t make the shedding of O91:H21 less of concern.
A previous survival study (Molina, Parma et al. 2003) in acidic and alcoholic
condition indicated that O91:H21 may be more resistant to stress conditions than
other STECs, including O157:H7. Therefore, this strain may persist within the
environment or contaminated food for a longer time. As for the shedding duration,
because the shedding experiment in this study only lasted for two weeks, it was
not known whether the fecal shedding of O91:H21 by calves could last for as
long as 20 weeks as observed in an O157:H7 shedding experiment (Cray and
Moon 1995). Calves in this study that were tested negative of the organism at
day 12 or day 14 PI may still carry the organism in their intestine and could shed
the organism intermittently if the experiment was extended.
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The contents of the cecum and colon tested positive for the O91:H21 in all
animals at day 14 PI, despite the fact that fecal samples from two of the animals
tested negative for the organism. This is consistent with many other studies that
considered the large intestine as the main habitat for STEC in cattle (Grauke,
Kudva et al. 2002).
Based on the results of this study, it is suggested that a chromosomal
based luxCDABE marker may be a better model than antibiotic resistance
markers for the study of STEC localization and shedding in cattle.
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Figure 1. Gompertz equation for the modeling of bacterial growth curve.
Originally in the equation, Y is the natural logarithm value of cell number, N 0 is
the natural logarithm value of initial cell number, A is the difference between
initial and final cell numbers, µmax is the maximum growth rate and λ is lag time.
Because there’s a linear relationship between the OD600 value and cell number,
OD600 values were interpolated where cell numbers were in the equation.
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Figure 2. Differentiation of bioluminescence-positive colonies from negative colonies on LB agar containing
50 ug/ml nalidixic acid and 50 ug/ml kanamycin using the FluorChem® imaging system. (A) the image of a
plate that was taken under artificial white light displayed both bioluminescence-positive and negative
colonies that were growing on the plate; (B) the image of the same plate that was taken in the dark displayed
only the bioluminescence-positive colonies; (C) for a convenient separation of bioluminescence-positive
colonies from negative colonies on a cluttered plate, the Overlay function in AlphaEase® FC software (Alpha
Innotech Corp, San Leandro, CA) was used to mark two images with different colors (red and green in this
example) and overlay one image on the other. Bioluminescence-positive colonies appeared yellow, and
bioluminescence-negative colonies appeared as the original red color.
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Figure 3. API 20E test (BioMerieux Vitch, Inc., Hazelwood, MO) for luxCDABEmarked O91:H21 construct and its donor and recipient strains.
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Figure 4. The insertion site of luxCDABE-carrying mini-Tn5 transposon on
chromosome (A) the insertion site was 27bp before the stop codon of yihL gene,
according to the complete genome sequence of Escherichia coli CFT073. (B)
DNA sequence of PCR product amplified by primers luxE and Yih. The box
indicates the position of the I-end of mini-Tn5 transposon.
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Figure 5. Growth curves of O91:H21 and its Lux- and GFP-marked constructs in
LB broth

72

Figure 6. Fecal shedding levels of wild type O91:H21 in three calves with
experimental infection
*Indigenous bacteria exhibiting nalidixic acid resistance was found among
colonies recovered from fecal samples collected at day 12 and day 14 PI in calf B
and from samples collected from day 10 to 14 PI from calf C. Therefore, the fecal
shedding levels at these sampling points in calf B and C were not reliable.
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Figure 7. Concentration of the wild type O91:H21 in bovine intestinal contents at
day 14 PI.
*Insufficient quantity of ileal contents was available for this calf during the
sampling
#
Indigenous bacteria exhibiting nalidixic acid resistance was found among
colonies recovered from fecal and intestinal samples collected from calf B and C
and was observed to confound the enumeration results. Therefore, the
concentrations were not reliable.
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Figure 8. Fecal shedding levels of luxCDABE-marked O91:H21 in four calves
with experimental infection
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Figure 9. Concentration of the luxCDABE-marked O91:H21 in bovine intestinal
contents at day 14 PI.
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